Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

Optimizing Bcl11b timing enhances natural killer cell differentiation and cytotoxicity from human pluripotent stem cells for effective immunotherapy

View Full Paper
Ask AI
Bookmark
Share

Authors

ABAndrew BaldysAWAnna WeisFCFrank Cichocki

Discussion

Loading...

Member takes

Overview

Genetic engineering of iPSCs to induce Bcl11b showed increased NK cell cytotoxicity and potential for immunotherapy.

Key Points

  • The research aims to understand the role of Bcl11b in natural killer cell differentiation from human pluripotent stem cells.
  • Used CRISPR/Cas9 to engineer hiPSCs for inducible Bcl11b overexpression
  • Investigated timing of Bcl11b expression during hematopoietic differentiation
  • Assessed in vivo engraftment and cytotoxicity of engineered NK cells in mice
  • Transient Bcl11b expression increased multipotent HPC frequencies
  • Generated NK cells displayed improved maturation and cytotoxic response
  • Bcl11b iNK cells showed better tumor control in vivo compared to wild-type NK cells

Cite This Study

Baldys et al. (2025) studied this question.

synapsesocial.com/papers/693624d44fa91c937236d07ahttps://doi.org/10.1182/blood-2025-3153
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The transcription factor BCL11B drives NK cell cytotoxicity and antitumor activity2025 · 2 citations
  2. 2Overcoming maturation deficits in iPSC-NK cells through programmable T-bet induction2025 · 1 citations
  3. 3Silencing of BCL11A by disrupting enhancer-dependent epigenetic insulation2025 · 1 citations
  4. 4A Bcl11bN797K variant isolated from an immunodeficient patient inhibits early thymocyte development in mice2024 · 3 citations
  5. 5Generation of iNKT cells with hematopoiesis-promoting properties from human iPSCs2025